Background illustration for clinical trials search

Paid Clinical Trials Toledo

Discover 754 paid clinical trials in Toledo, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer

for
HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer
Location: Ypsilanti MI, Cleveland OH, Hinsdale IL, Hershey PA,
Sponsor: SynDevRx, Inc.

Sex: All

Age: 18+

Code: NCT05455619

Phase1, Phase2, Recruiting

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Ann Arbor MI, Canton MI, Chelsea MI, Livonia MI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06770582

Phase2, Recruiting

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

for
Breast Cancer, TNBC - Triple-Negative Breast Cancer,
Location: Ann Arbor MI, Goshen IN, Cincinnati OH, O'Fallon IL,
Sponsor: Tempus AI

Sex: All

Age: 18 - 70+

Code: NCT07211178

Recruiting

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for
Carcinoma, Non-Small-Cell Lung
Location: Ypsilanti MI, Ann Arbor MI, Fort Wayne IN,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06667076

Phase2, Recruiting

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

for
Malignant Digestive System Neoplasm,
Location: Ann Arbor MI, Chelsea MI, Livonia MI, Pontiac MI,
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT07215624

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

for
Squamous Cell Carcinoma of Head and Neck
Location: Ann Arbor MI, Detroit MI, Columbus OH, Cincinnati OH,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07276399

Phase3, Recruiting

A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

for
Atrial Fibrillation
Location: Ypsilanti MI, Springfield OH, Cincinnati OH,
Sponsor: Biosense Webster, Inc.

Sex: All

Age: 22+

Code: NCT07227532

Recruiting

BoxX-NoAF Clinical Trial

for
Post Operative Atrial Fibrillation,
Location: Ypsilanti MI, Cleveland OH, Grand Rapids MI, London,
Sponsor: AtriCure, Inc.

Sex: All

Age: 65+

Code: NCT06989775

Recruiting

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

for
Acute Decompensated Heart Failure
Location: Ann Arbor MI, Royal Oak MI, Cleveland OH, Columbus OH,
Sponsor: Reprieve Cardiovascular, Inc

Sex: All

Age: 22+

Code: NCT06898515

Phase3, Recruiting

Get Going: Accelerometer-Based Intervention to Promote Physical Activity in Frail Older Adults

for
Coronary Artery Disease, Heart Failure
Location: Ypsilanti MI, Ann Arbor MI, Dearborn MI, Cleveland OH,
Sponsor: American College of Cardiology

Sex: All

Age: 70+

Code: NCT02635477

Recruiting

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia,
Location: Ann Arbor MI, Ypsilanti MI, Canton MI, Chelsea MI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase2, Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

for
Ovarian Cancer
Location: Ann Arbor MI, Centerville OH, Grand Rapids MI,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT06819007

Phase3, Recruiting

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for
Acute Myeloid Leukemia,
Location: Ann Arbor MI, Ypsilanti MI, Canton MI, Chelsea MI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05564390

Phase2, Recruiting

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

for
Metastatic Renal Cell Carcinoma,
Location: Ann Arbor MI, Ypsilanti MI, Canton MI, Dearborn MI,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05327686

Phase2, Recruiting

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

for
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors
Location: Ann Arbor MI, Livonia MI, Detroit MI, Warren MI,
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 12+

Code: NCT02693535

Phase2, Recruiting

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

for
Metastatic Colorectal Adenocarcinoma,
Location: Ann Arbor MI, Ypsilanti MI, Canton MI, Dearborn MI,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT05673148

Phase2, Recruiting

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

for
Malignant Female Reproductive System Neoplasm,
Location: Ann Arbor MI, Ypsilanti MI, Canton MI, Chelsea MI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06126276

Phase2, Recruiting

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for
Myelodysplastic Syndrome
Location: Ypsilanti MI, Canton MI, Chelsea MI, Livonia MI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06577441

Phase2, Recruiting

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Ypsilanti MI, Canton MI, Ann Arbor MI, Chelsea MI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06498635

Phase3, Recruiting

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

for
Locally Advanced Urothelial Carcinoma,
Location: Ypsilanti MI, Canton MI, Chelsea MI, Livonia MI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06524544

Phase3, Recruiting